Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia

NCT05011162 is registered in ClinicalTrials.gov with Swing Therapeutics, Inc. as lead sponsor.

NCT NCT05011162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05011162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"REACT-FM" Real-World Evidence From Smartphone-Based Acceptance and Commitment Therapy in Fibromyalgia
Lead sponsor
Swing Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 25, 2021
Completion date
March 5, 2024
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia